With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

In 2019, Evotec acquired Just Biotherapeutics, an AI/ML antibody discovery ... AI-small molecule discovery spaces Compared to the small molecule AI drug discovery ecosystem, this space is evolving ...

In this article, we present a framework designed to evaluate the progress and impact of AI tools across various use cases in drug discovery ... is gaining momentum in antibody drug design ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and .

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

Absci's advanced de novo antibody design models will benefit from AMD's optimized AI solutions, potentially leading to reduced infrastructure costs and faster innovation cycles in drug discovery.

Absci Corporation and Owkin have announced a partnership to combine their advanced AI platforms for the rapid discovery ... AI Drug Creation platform, including its de novo antibody design models ...

GUILFORD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize ...